Reactive oxygen species-responsive HET0016 prodrug-loaded liposomes attenuate neuroinflammation and improve neurological deficit in a rat model of juvenile traumatic brain injury

The arachidonic acid pathway metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) contributes to ischemia/reperfusion brain injury. Inhibition of 20-HETE formation can protect the developing brain from global ischemia. In previous studies, we have found that treatment with the 20-HETE synthesis inhi...

Full description

Bibliographic Details
Main Authors: Jun Qin, Xiaoli Chen, Rui Wang, Zedan Tian, Yang Li, Shiyu Shu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2023.1153349/full
_version_ 1797866054528008192
author Jun Qin
Xiaoli Chen
Rui Wang
Zedan Tian
Yang Li
Shiyu Shu
author_facet Jun Qin
Xiaoli Chen
Rui Wang
Zedan Tian
Yang Li
Shiyu Shu
author_sort Jun Qin
collection DOAJ
description The arachidonic acid pathway metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) contributes to ischemia/reperfusion brain injury. Inhibition of 20-HETE formation can protect the developing brain from global ischemia. In previous studies, we have found that treatment with the 20-HETE synthesis inhibitor N-hydroxy-N-4-butyl-2-methylphenylformamidine (HET0016) can protect the immature brain from traumatic brain injury (TBI), but its hydrophobic nature limits its full potential. We designed a reactive oxygen species-responsive HET0016 prodrug, which consists of a thioketal link between HET0016 and stearyl alcohol (HET-TK-SA), and used the nanoprodrug strategy to successfully synthesize liposomes HET0016 prodrug liposomes (HPLs) to facilitate the application of HET0016 in protection from TBI. HPLs demonstrated spherical shape, size of about 127.8 nm, a zeta potential of −28.8 mv, a narrow particle size distribution and good stability. Male rats at postnatal day 16–17 underwent controlled cortical impact (CCI) followed by intravenous injection with vehicle or HET0016 (1 mg/kg, 2 h post-injury, once/day for 3 days). The results of the in vivo demonstrated that HPLs has good biosafety and can pass through the blood-brain barrier. Not only that compared with HET0016, HPLs better-inhibited inflammation and improved neuronal degeneration, which further led to lesion volume reduction, upgraded behavioral task performance, and ameliorated the degree of TBI impairment. Our results demonstrated HPLs could be a new strategy for juvenile TBI therapy.
first_indexed 2024-04-09T23:18:57Z
format Article
id doaj.art-ccfe6308c59e4cbb8b212524f28b061e
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-04-09T23:18:57Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-ccfe6308c59e4cbb8b212524f28b061e2023-03-22T04:50:13ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2023-03-011710.3389/fnins.2023.11533491153349Reactive oxygen species-responsive HET0016 prodrug-loaded liposomes attenuate neuroinflammation and improve neurological deficit in a rat model of juvenile traumatic brain injuryJun Qin0Xiaoli Chen1Rui Wang2Zedan Tian3Yang Li4Shiyu Shu5Department of Anesthesiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Anesthesiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaCollege of Pharmacy, Chongqing Medical University, Chongqing, ChinaDepartment of Anesthesiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaCollege of Pharmacy, Chongqing Medical University, Chongqing, ChinaDepartment of Anesthesiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaThe arachidonic acid pathway metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) contributes to ischemia/reperfusion brain injury. Inhibition of 20-HETE formation can protect the developing brain from global ischemia. In previous studies, we have found that treatment with the 20-HETE synthesis inhibitor N-hydroxy-N-4-butyl-2-methylphenylformamidine (HET0016) can protect the immature brain from traumatic brain injury (TBI), but its hydrophobic nature limits its full potential. We designed a reactive oxygen species-responsive HET0016 prodrug, which consists of a thioketal link between HET0016 and stearyl alcohol (HET-TK-SA), and used the nanoprodrug strategy to successfully synthesize liposomes HET0016 prodrug liposomes (HPLs) to facilitate the application of HET0016 in protection from TBI. HPLs demonstrated spherical shape, size of about 127.8 nm, a zeta potential of −28.8 mv, a narrow particle size distribution and good stability. Male rats at postnatal day 16–17 underwent controlled cortical impact (CCI) followed by intravenous injection with vehicle or HET0016 (1 mg/kg, 2 h post-injury, once/day for 3 days). The results of the in vivo demonstrated that HPLs has good biosafety and can pass through the blood-brain barrier. Not only that compared with HET0016, HPLs better-inhibited inflammation and improved neuronal degeneration, which further led to lesion volume reduction, upgraded behavioral task performance, and ameliorated the degree of TBI impairment. Our results demonstrated HPLs could be a new strategy for juvenile TBI therapy.https://www.frontiersin.org/articles/10.3389/fnins.2023.1153349/fulltraumatic brain injuryHET0016neuroinflammationreactive oxygen species responsiveliposomes
spellingShingle Jun Qin
Xiaoli Chen
Rui Wang
Zedan Tian
Yang Li
Shiyu Shu
Reactive oxygen species-responsive HET0016 prodrug-loaded liposomes attenuate neuroinflammation and improve neurological deficit in a rat model of juvenile traumatic brain injury
Frontiers in Neuroscience
traumatic brain injury
HET0016
neuroinflammation
reactive oxygen species responsive
liposomes
title Reactive oxygen species-responsive HET0016 prodrug-loaded liposomes attenuate neuroinflammation and improve neurological deficit in a rat model of juvenile traumatic brain injury
title_full Reactive oxygen species-responsive HET0016 prodrug-loaded liposomes attenuate neuroinflammation and improve neurological deficit in a rat model of juvenile traumatic brain injury
title_fullStr Reactive oxygen species-responsive HET0016 prodrug-loaded liposomes attenuate neuroinflammation and improve neurological deficit in a rat model of juvenile traumatic brain injury
title_full_unstemmed Reactive oxygen species-responsive HET0016 prodrug-loaded liposomes attenuate neuroinflammation and improve neurological deficit in a rat model of juvenile traumatic brain injury
title_short Reactive oxygen species-responsive HET0016 prodrug-loaded liposomes attenuate neuroinflammation and improve neurological deficit in a rat model of juvenile traumatic brain injury
title_sort reactive oxygen species responsive het0016 prodrug loaded liposomes attenuate neuroinflammation and improve neurological deficit in a rat model of juvenile traumatic brain injury
topic traumatic brain injury
HET0016
neuroinflammation
reactive oxygen species responsive
liposomes
url https://www.frontiersin.org/articles/10.3389/fnins.2023.1153349/full
work_keys_str_mv AT junqin reactiveoxygenspeciesresponsivehet0016prodrugloadedliposomesattenuateneuroinflammationandimproveneurologicaldeficitinaratmodelofjuveniletraumaticbraininjury
AT xiaolichen reactiveoxygenspeciesresponsivehet0016prodrugloadedliposomesattenuateneuroinflammationandimproveneurologicaldeficitinaratmodelofjuveniletraumaticbraininjury
AT ruiwang reactiveoxygenspeciesresponsivehet0016prodrugloadedliposomesattenuateneuroinflammationandimproveneurologicaldeficitinaratmodelofjuveniletraumaticbraininjury
AT zedantian reactiveoxygenspeciesresponsivehet0016prodrugloadedliposomesattenuateneuroinflammationandimproveneurologicaldeficitinaratmodelofjuveniletraumaticbraininjury
AT yangli reactiveoxygenspeciesresponsivehet0016prodrugloadedliposomesattenuateneuroinflammationandimproveneurologicaldeficitinaratmodelofjuveniletraumaticbraininjury
AT shiyushu reactiveoxygenspeciesresponsivehet0016prodrugloadedliposomesattenuateneuroinflammationandimproveneurologicaldeficitinaratmodelofjuveniletraumaticbraininjury